Skip to main content
All lobbying filings

AXADVOCACY GOVERNMENT RELATIONS

Lobbying for REPLIMUNE · Biotech company focused on resolution of cancer treatment.

 Filing 2nd Quarter - Termination
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $20,000.00 income · posted Jun 2, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to FDA drug approval processes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem